Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT01568333
Eligibility Criteria:
Inclusion Criteria:
* adult patients with the diagnosis of ITP according to the International Working Group (IWG) guidelines
* failure to splenectomy or at least four standard ITP-specific treatments, but not necessarily undergone splenectomye
* baseline peripheral platelet count less than 30,000/uL or the presence of bleeding symptoms
* need of treatment(s) (including, but not limited to, low dose of corticosteroids) to minimize the risk of clinically significant bleeding. Need of on-demand or
Exclusion Criteria:
* secondary ITP
* pregnancy
* hypertension
* cardiovascular disease
* diabetes
* liver and kidney function impairment
* HCV, HIV, HBsAg seropositive status
* patients with systemic lupus erythematosus and/or antiphospholipid syndrome
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01568333
Study Brief:
Protocol Section:
NCT01568333